A Study of The Effect of Using Topical Corticosteroids on The Face of Iraqi Patients Between The Ages of 15 Years and 40 Years
Keywords:
Topical corticosteroids (TCS); Acne vulgaris; Melasma; and Hypertrichosis Introduction.Abstract
Background:
Numerous dermatological conditions have been treated using topical corticosteroids (TCS). However, due to unintentional usage, TCS abuse has emerged as a widespread issue for dermatologists throughout the globe.
Objective:
This paper aims to study the effect of using topical corticosteroids on the face of Iraqi patients between the ages of 15 years and 40 years.
Patients and methods:
This paper encountered to study the effect of using topical corticosteroids on the face of Iraqi patients between the ages of 15 years and 40 years. To follow up of the study methodology, this paper was processed of data with 104 patients in different hospitals in Iraq for ages under 40 years from 17th July 2021 to 24th February 2022. Our study was analysed and progresses of data methodology by the SPSS program.
Discussion:
Males outnumbered girls in the current survey, contrary to earlier American investigations where the proportion of females was stated to be considerably greater. Moreover, acne aggravation, come-done development, or acneiform eruption were the most frequent side effects identified in the research, followed by topical steroid-dependent facies (TSDF) with steroid-modified dermatophytosis. In addition, this is consistent with a prior study carried out in California. Even though some female patients (16%) used TCS as part of their regular skin care regimen without having any skin conditions, the percentage of these patients was quite low in the current study. Drug combinations were the most often employed TCS compositions, followed by steroids and antibiotics.
Conclusion:
Topical corticosteroids, such as top steroids, commonly known as TOP steroids, have been linked to adverse cutaneous reactions. The facial dermatitis, which manifests as severe erythema and can mimic rosacea, is caused by using high-potency topical corticosteroids to the face. It can affect the cheek area as well as the perioral and perinasal regions. The primary treatment action following diagnosis is stopping the high-potency corticosteroid.
